The latest brain, head and neck cancer news
Programming cells to target brain tumours
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
The latest brain, head and neck cancer news
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
Drugs that are effective against brain tumours are difficult to find, as many cancer drugs…
Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking…
A new study from researchers with the Advanced Science Research Center at the CUNY Graduate…
Researchers at the University of Notre Dame, USAm have developed a novel, automated device capable…
Ribociclib – a drug already used to treat breast cancer – may help slow the…
A study from Keck Medicine, USA, suggests that cannabis, the most commonly used illicit substance…
Oral Leukoplakia (OLK) is recognised as a predominant potentially malignant oral epithelial lesion (PMOEL), posing…
In an effort to combat one of the most lethal forms of paediatric brain cancer,…
A transformative study has provided a profound understanding of glioblastoma’s molecular subtypes, revealing the nuances…